Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Stroke. 2017 May 9;48(6):1636–1645. doi: 10.1161/STROKEAHA.117.016650

Figure 1.

Figure 1

Post-stroke SAG treatment enhanced functional recovery in both locomotor function and cognitive function. (A). locomotor function measured by automatic open field locomotion chambers at different time points in vehicle or SAG-treated (post-stroke day 3–8) mice. Multiple parameters are shown as labeled in panels. MEAN ± SEM. # or ## p<0.05 or p<0.01, two-way ANOVA vehicle vs SAG. * or **, p<0.05 or p<0.01, post-hoc Newman-Keuls test (B). Barnes maze test showing time spent and missed trials before mice found the escape hole in control or stroke mice that received vehicle or SAG treatment. *or **, p<0.05 or p<0.01, control vs stroke and ##, p<0.01, vehicle vs SAG.